Mark Fishman

Professor in the Harvard Department of Stem Cell and Regenerative Biology and Chief of the Pathways Clinical Service at Massachusetts General Hospital; former founding President of the Novartis Institutes for BioMedical Research, known for zebrafish-based cardiovascular and developmental biology research and work on drug discovery and translational medicine.